vs
Side-by-side financial comparison of Entrada Therapeutics, Inc. (TRDA) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.
UNITY BANCORP INC is the larger business by last-quarter revenue ($35.3M vs $20.6M, roughly 1.7× Entrada Therapeutics, Inc.). UNITY BANCORP INC runs the higher net margin — 43.9% vs -84.4%, a 128.3% gap on every dollar of revenue. On growth, UNITY BANCORP INC posted the faster year-over-year revenue change (24.2% vs -65.2%). UNITY BANCORP INC produced more free cash flow last quarter ($44.3M vs $-39.7M). Over the past eight quarters, UNITY BANCORP INC's revenue compounded faster (17.5% CAGR vs 6.4%).
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
TRDA vs UNTY — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.6M | $35.3M |
| Net Profit | $-17.3M | $15.5M |
| Gross Margin | — | — |
| Operating Margin | -106.0% | 55.8% |
| Net Margin | -84.4% | 43.9% |
| Revenue YoY | -65.2% | 24.2% |
| Net Profit YoY | -173.8% | 34.5% |
| EPS (diluted) | $-0.42 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $35.3M | ||
| Q3 25 | — | $32.8M | ||
| Q2 25 | — | $34.4M | ||
| Q1 25 | $20.6M | $29.4M | ||
| Q4 24 | $37.4M | $28.4M | ||
| Q3 24 | $19.6M | $27.7M | ||
| Q2 24 | $94.7M | $25.5M | ||
| Q1 24 | $59.1M | $25.6M |
| Q4 25 | — | $15.5M | ||
| Q3 25 | — | $14.4M | ||
| Q2 25 | — | $16.5M | ||
| Q1 25 | $-17.3M | $11.6M | ||
| Q4 24 | $1.1M | $11.5M | ||
| Q3 24 | $-14.0M | $10.9M | ||
| Q2 24 | $55.0M | $9.5M | ||
| Q1 24 | $23.5M | $9.6M |
| Q4 25 | — | 55.8% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 62.6% | ||
| Q1 25 | -106.0% | 52.6% | ||
| Q4 24 | -15.7% | 51.0% | ||
| Q3 24 | -110.7% | 52.7% | ||
| Q2 24 | 56.4% | 49.3% | ||
| Q1 24 | 35.7% | 50.0% |
| Q4 25 | — | 43.9% | ||
| Q3 25 | — | 43.8% | ||
| Q2 25 | — | 48.0% | ||
| Q1 25 | -84.4% | 39.5% | ||
| Q4 24 | 3.0% | 40.5% | ||
| Q3 24 | -71.7% | 39.4% | ||
| Q2 24 | 58.1% | 37.1% | ||
| Q1 24 | 39.7% | 37.5% |
| Q4 25 | — | $1.52 | ||
| Q3 25 | — | $1.41 | ||
| Q2 25 | — | $1.61 | ||
| Q1 25 | $-0.42 | $1.13 | ||
| Q4 24 | $-0.20 | $1.13 | ||
| Q3 24 | $-0.35 | $1.07 | ||
| Q2 24 | $1.55 | $0.92 | ||
| Q1 24 | $0.68 | $0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $67.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $417.3M | $345.6M |
| Total Assets | $486.5M | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $67.8M | — | ||
| Q4 24 | $101.2M | — | ||
| Q3 24 | $78.0M | — | ||
| Q2 24 | $185.3M | — | ||
| Q1 24 | $68.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $230.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $345.6M | ||
| Q3 25 | — | $334.0M | ||
| Q2 25 | — | $319.8M | ||
| Q1 25 | $417.3M | $306.1M | ||
| Q4 24 | $428.7M | $295.6M | ||
| Q3 24 | $422.4M | $284.3M | ||
| Q2 24 | $429.9M | $273.4M | ||
| Q1 24 | $269.4M | $266.8M |
| Q4 25 | — | $3.0B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | $486.5M | $2.8B | ||
| Q4 24 | $526.3M | $2.7B | ||
| Q3 24 | $554.6M | $2.6B | ||
| Q2 24 | $582.0M | $2.6B | ||
| Q1 24 | $510.8M | $2.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-38.5M | $44.9M |
| Free Cash FlowOCF − Capex | $-39.7M | $44.3M |
| FCF MarginFCF / Revenue | -192.9% | 125.7% |
| Capex IntensityCapex / Revenue | 5.6% | 1.6% |
| Cash ConversionOCF / Net Profit | — | 2.90× |
| TTM Free Cash FlowTrailing 4 quarters | $-58.0M | $81.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $44.9M | ||
| Q3 25 | — | $45.5M | ||
| Q2 25 | — | $-25.3M | ||
| Q1 25 | $-38.5M | $17.9M | ||
| Q4 24 | $-31.6M | $48.0M | ||
| Q3 24 | $-24.3M | $17.7M | ||
| Q2 24 | $39.8M | $-8.4M | ||
| Q1 24 | $-25.5M | $15.8M |
| Q4 25 | — | $44.3M | ||
| Q3 25 | — | $45.3M | ||
| Q2 25 | — | $-25.5M | ||
| Q1 25 | $-39.7M | $17.6M | ||
| Q4 24 | $-32.2M | $47.3M | ||
| Q3 24 | $-24.9M | $17.5M | ||
| Q2 24 | $38.8M | $-8.6M | ||
| Q1 24 | $-26.4M | $15.7M |
| Q4 25 | — | 125.7% | ||
| Q3 25 | — | 138.1% | ||
| Q2 25 | — | -74.2% | ||
| Q1 25 | -192.9% | 59.9% | ||
| Q4 24 | -86.2% | 166.5% | ||
| Q3 24 | -127.3% | 63.3% | ||
| Q2 24 | 41.0% | -33.7% | ||
| Q1 24 | -44.6% | 61.4% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | 5.6% | 1.0% | ||
| Q4 24 | 1.7% | 2.4% | ||
| Q3 24 | 3.3% | 0.5% | ||
| Q2 24 | 1.1% | 0.5% | ||
| Q1 24 | 1.4% | 0.3% |
| Q4 25 | — | 2.90× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | — | -1.54× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | -27.94× | 4.17× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | 0.72× | -0.89× | ||
| Q1 24 | -1.09× | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
